Assenagon Asset Management S.A.
Position in COGT — Cogent Biosciences, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in COGT
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$55,795,957
+$44,416,389 QoQ
Shares Held
1,441,756
+387.7% QoQ
Ownership
0.831%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#31
of 323 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. COGT ranks #9 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in COGT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,795,957 | 1,441,756 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $11,379,568 | 295,650 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $13,342,235 | 375,626 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $8,285,777 | 577,004 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,412,011 | 196,659 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,837,421 | 473,693 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,694,805 | 473,693 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $6,557,846 | 607,208 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,064,440 | 600,764 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,037,134 | 600,764 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,532,492 | 600,764 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $5,936,755 | 608,898 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $8,267,528 | 698,271 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $7,534,344 | 698,271 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $8,072,012 | 698,271 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $14,750,449 | 988,636 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $8,917,496 | 988,636 | Shares | Sole | 2022-07-27 | |
| No filing history on record for this holder in this stock. | ||||||